2[14]Seki Y, Takahashi H, Shibata A, et al. Plasma levels of thrombomodulin and lipoprotein[a] in patients with cerebral thrombosis. Blood Coagul Fibrinolysis1997; 8:391
3[16]Kario K, Matsuo T, Kobayashi H, et al. "silent" cerebral infarction is associated with hypercoagulability, endothelial cell damage and high Lp[a] levels in elderly Japanese. Arterioscler Thromb Vasc Biol 1996; 16:734
4[17]Shinichiro U, Masako Y, Yukiko H, et al. Alteration of platelet, coagulation, and fibrinolysis markers in patients with acute ischemic stroke. Seminars Tromb Hem os1997; 23(6): 535 -41
5[18]Hideo T, Masahiro K, Kenichi T, et al. Coagulation-fibrinolysis abnormalities in acute and chronic phases of cerebral thrombosis and embolism. Stroke 1990; 21:1663 - 7
6[5]Califano F, Giovanniello T, Pantone P, et al. Clinical importance of thrombomodulin serum levels. Eur Rev Med Pharmacol Sci 2000; 4(3): 59 - 66
7[6]Van der Bom JG, Bots, ML, Haverkate F, et al. Activation products of the hameostatic system in coronary, cerebrovascular and peripheral arterial disease. Thromb Haemost 2001; 85 (2): 234 - 9
8[8]Takano S, Kimura S, Ohdama S. Plasma thrombomodulin in health and disease. Blood 1990; 6:2024 - 5
9[10]Hassan A, Hunt BJ, O' sullivan M, et al. Markers of endothelial dysfunction in lacunar infarction and ischemic leukoaraiosis. Brain 2003; 126(pt 2): 424 -32
10[11]Takahashi H, Ito S, Hanana M, et al. Circulating thrombomodulin as a novel endothelial cell marker comparison of its behavior with yon Willebrand factor and tissue-type plasminogen activator. Am J Hematol 1992, 41:32 - 3
